An anonymous survey of founders, CEOs and board members about the parts of the job nobody asks about. Seven minutes. No name, no company, no email. The full results, the questions and the anonymized raw data will be published free in November 2026.
There is a great deal of research on loneliness. Almost none of it asks senior leaders, and the little that does rarely asks the questions that matter: whether you have ever said any of it out loud, and to whom.
We are Inlibrium. We sell a six-month medically supervised psychedelic-assisted program for executives, and it is expensive. That is a real conflict of interest and pretending otherwise would be the fastest way to make this survey worthless.
So here is what we are doing about it, and you can hold us to all six:
We decided what we would report before we collected anything. The analysis plan — which numbers we publish, where the cutoffs sit, which comparisons we make — was written, dated and locked before the first response came in, and it is published alongside the report. If we later report something that is not in it, you will be able to see that we changed our mind after seeing the data.
Some of the questions are not ours. The three loneliness questions are the UCLA Loneliness Scale, used in large population studies for two decades, asked word for word. The burnout question is a published measure validated against the standard clinical instrument. We did not write them, we cannot tune them, and using them means our numbers can be set beside everyone else’s rather than floating on their own.
We publish the questions in full. Every question, in the order asked, as an appendix to the report. If a question is leading, you will be able to see that it was leading.
We publish the raw anonymized dataset. CSV, free, no email. Anyone can re-run the numbers and check whether our summary matches the data. Almost no commercial survey does this, which is precisely why we are doing it.
We publish the findings that do not help us. If most leaders say they are not lonely, that goes in the headline. If the people who tried psychedelic work without clinical support report doing fine, that goes in too.
We say plainly which questions are ours and unvalidated. Most of this survey is written by us. Those questions produce descriptive numbers — how many people said what — and we do not dress them up as clinical measures. The report marks which is which.
We say plainly that this is a convenience sample. It is not a random sample of the world’s executives and no survey distributed this way ever is. That is a genuine limitation, and it is only a problem when it is hidden.
What we do not do: we do not ask for your email to give you the report, we do not sell or share anything, and we will not contact you. The report will simply be on this page.
Is it really anonymous?
Yes, and structurally rather than as a promise. We do not ask for your name, your company or your email, so there is nothing to connect an answer to a person. If you want the report, the last screen offers a link to a separate form that asks only for an email address. It is a different form in a different place — your address is never written on the same row as your answers, because they are never collected together.
How long does it take?
About seven minutes. Only the first question is required — it establishes whether you are in the group this survey is about. Everything after it is optional.
Why are there questions about psychedelics?
Because the honest version of this subject is not in the public record. There is a great deal of marketing about psychedelic work with executives and almost no data about how many have actually done it, or how many did it with medical screening rather than a facilitator and a hope. We would rather find that number than assert it. It is the number most likely to be uncomfortable for us.
What happens to the results?
Published in November 2026 on this page: the findings, the full question set, and the anonymized raw data. Free, no registration. Journalists and researchers are welcome to use it with attribution.
Who can take it?
Founders, CEOs, C-level executives and board members. The first question establishes that, and responses outside it are excluded from the published sample rather than quietly folded in.
Five areas, in this order:
Meaning — whether the work still connects to anything, and what changed.
Isolation — who you can say the true version to, and whether you ever have.
Body and sustainability — burnout, health, and what you have been postponing.
Seeking support — what you have tried, what stopped you, and what you would never put in writing.
Psychedelic-assisted work — whether you have considered it, whether you have done it, and whether anyone medical was involved.
Demographics come before the last section, not after, so that a response that stops at the sensitive questions is still usable for everything preceding it.
This is not a diagnostic instrument and it produces no score, no result and no advice. If any of it lands somewhere difficult, a doctor or a mental-health professional is the right next step, not us and not a form.
The Executive Loneliness Index, 2026 edition. Fielded August–October 2026. Results published November 2026.